FdaApplication
NDA 204623
Identifiers
- fda_app_no: NDA204623
Properties
| Property | Value |
|---|---|
| applicant_name | HORIZON THERAPEUTICS IRELAND DAC |
| application_type | NDA |
| approval_date | 2014-01-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PENNSAID | DICLOFENAC SODIUM | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION;TOPICAL |
1 product